Choroidal Neovascularization (CNV) Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Choroidal Neovascularization (CNV) Market
Choroidal Neovascularization (CNV) Market: By Treatment Type (Angiogenesis Inhibitors Injection, Photodynamic Therapy, Surgery), By Diagnosis Types & By Geography- Forecast (2018- 2023)
Report Code : HCR 0119
Updated Date: 12 March, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Choroidal Neovascularization (CNV) Market Overview 
2. Executive Summary  
3. Choroidal Neovascularization (CNV) Market Landscape 
   3.1. Market Share Analysis 
   3.2. Comparative Analysis 
      3.2.1. End-User Profiling 
      3.2.2. Patent Analysis 
      3.2.3. Financial Analysis of Top 5 Players 
4. Choroidal Neovascularization (CNV) Market Forces 
   4.1. Market Drivers 
   4.2. Market Constraints 
   4.3. Market Challenges  
   4.4. Attractiveness of Industry  
      4.4.1. Power of Supplier 
      4.4.2. Power of Consumer 
      4.4.3. Threat of New Entrants 
      4.4.4. Threat of Substitution 
      4.4.5. Degree of Competition 
5. Choroidal Neovascularization (CNV) Market Strategic Analysis 
   5.1. Value Chain Analysis 
   5.2. Pricing Analysis  
   5.3. Opportunity Analysis 
   5.4. Product Life Cycle Analysis  
   5.5. Suppliers & Distributors 
6. Choroidal Neovascularization (CNV) Market Analysis - By Treatment Type 
   6.1. Angiogenesis Inhibitors Injection 
   6.2. Photodynamic Therapy 
   6.3. Laser photocoagulation 
   6.4. Low-dose Radiation Therapy 
   6.5. Surgery 
7. Choroidal Neovascularization (CNV) Market Analysis- By Type of Diagnosis 
   7.1. Fluorescein angiography (FA) 
   7.2. Indocyanine green (ICG) angiography 
   7.3. Spectral domain optical coherence tomography (OCT) 
   7.4. Others 
8. Choroidal Neovascularization (CNV) Market Analysis- By Geography 
   8.1. North America 
      8.1.1. The U.S. 
      8.1.2. Canada 
      8.1.3. Rest of North America 
   8.2. Europe 
      8.2.1. The U.K. 
      8.2.2. Germany 
      8.2.3. France 
      8.2.4. Spain 
      8.2.5. Italy 
      8.2.6. Rest of Europe 
   8.3. Asia-Pacific 
      8.3.1. China 
      8.3.2. India 
      8.3.3. Japan 
      8.3.4. Australia 
      8.3.5. Rest of APAC 
   8.4. Latin America 
      8.4.1. Brazil 
      8.4.2. Argentina 
      8.4.3. Mexico 
      8.4.4. Rest of Latin America 
   8.5. Rest of the World 
      8.5.1. The Middle East 
      8.5.2. Africa 
9. Choroidal Neovascularization (CNV) Market Entropy 
   9.1. New Product Launches 
   9.2. M&As, Collaborations, Partnerships & JVs 
10. Company Profiles (Overview, Financials, Products & Services, Recent Developments, Competitors & Customers) 
   10.1. Pfizer Inc. 
   10.2. F. Hoffmann-La Roche Ltd. 
   10.3. Novartis AG 
   10.4. Regeneron Pharmaceuticals Inc. 
   10.5. Bayer AG 
   10.6. QLT Inc. 
   10.7. Sanwa Kagaku Kenkyusho Co. Ltd. 
   10.8. Promedior Inc. 
   10.9. Valeant Pharmaceuticals International Inc. 
   10.10. Gilead Sciences Inc 
*More than 10 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix 
   11.1. Abbreviations 
   11.2. Sources 
   11.3. Research Methodology 
   11.4. Bibliography 
   11.5. Compilation of Expert Insights 
Choroidal Neovascularization (CNV) is rapidly occurring in the population with defects in the innermost layer of the choroid called Bruch's membrane. It is associated with generation of new blood vessels in the choroidal layer of eye. These blood vessels abruptly break into the retina and cause disruption and sight loss/vision loss. The major signs and symptoms of this disorder are loss of vision, Metamorphopsia, paracentral or central scotoma and apparent change in image size. This disease mostly occurs in aged group of population and people with severe myopia.

There are several methods for the diagnosis of Choroidal Neovascularization (CNV) including Fluorescein Angiography (FA), Indocyanine Green (ICG) angiography , and spectral domain Optical Coherence Tomography (OCT). Fluorescein Angiography (FA) is most commonly used diagnosis methods. Nowadays, spectral domain OCT has largely replaced FA owing to its advantages and highly precise diagnosis. In view of the fact that CNV often initiate from posterior pole lesions and hence is hard to detect. A very accurate and precise diagnosis is obligatory to get rid of CNV. The report covers detailed analysis of all types of diagnosis methods of CNV along with the various treatments. The major treatments of CNV are angiogenesis inhibitors injection, photodynamic therapy, laser photocoagulation, low dose radiation therapy and surgery. The angiogenesis inhibitor injection is the conventional method to control the growth of blood vessels by reducing the area of fluid below the retinal pigment epithelium.

The report includes the major market dynamic factors such as drivers, restraints, challenges and opportunities and their impact on the industry in next 5 years. The high rate of increase in CNV affected patients due to increasing aged population is the major factor driving the growth of this market. Governments and heath care departments across the world are taking initiatives towards spreading awareness about the disease and providing diagnosis and treatments at affordable prices. This is also helping in driving the growth of CNV detection and treatment market. However, high lack of awareness among people majorly in the African and Asian regions about different types of eye diseases and high cost associated with its treatment are the major factors inhibiting the growth of this market. Moreover, unavailability of good healthcare infrastructure, better facilities and high grade care of patients are still some of the major challenges in this market.

Choroidal Neovascularization (CNV) Market

The report identifies and analyzes the key industry factors affecting the revenue generation in the CNV treatment market. The report tracks the entire value chain of the market along with the suppliers and distributor analysis. Moreover, the industry attractiveness section in the offers the significance of the competitive rivalry in the market affected by the forces such as power of supplier, power of buyer, threat of new entrant and threat of substitution. The report provides precise and comprehensive insights on the market trends, industry trends and macro & micro factors impacting the market growth.

Major geographies of North America, Europe, Asia-Pacific and Latin America are tracked and analyzed in the report. Due to the large number of aged population in North America, the region is estimated to be highly affected by this disease. Asia-Pacific region is expected to grow with high rate in next 5 years majorly in the countries of China, and India. 

The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. 

Sample Companies Profiled in this Report are: 
  • Bayer AG
  • Chengdu Kanghong Biotech Co. Ltd
  • Resolvyx Pharmaceuticals Inc
  • F. Hoffmann-La Roche Ltd
  • Valeant Pharmaceuticals International Inc.
  • 10+
List of Tables

Table 1: Choroidal Neovascularization (CNV) Market Overview 2017-2023
Table 2: Choroidal Neovascularization (CNV) Market Leader Analysis 2017-2018 (US$)
Table 3: Choroidal Neovascularization (CNV) Market Product Analysis 2017-2018 (US$)
Table 4: Choroidal Neovascularization (CNV) Market End User Analysis 2017-2018 (US$)
Table 5: Choroidal Neovascularization (CNV) Market Patent Analysis 2013-2018* (US$)
Table 6: Choroidal Neovascularization (CNV) Market Financial Analysis 2017-2018 (US$)
Table 7: Choroidal Neovascularization (CNV) Market Driver Analysis 2017-2018 (US$)
Table 8: Choroidal Neovascularization (CNV) Market Challenges Analysis 2017-2018 (US$)
Table 9: Choroidal Neovascularization (CNV) Market Constraint Analysis 2017-2018 (US$)
Table 10: Choroidal Neovascularization (CNV) Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11: Choroidal Neovascularization (CNV) Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12: Choroidal Neovascularization (CNV) Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13: Choroidal Neovascularization (CNV) Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14: Choroidal Neovascularization (CNV) Market Degree of Competition Analysis 2017-2018 (US$)
Table 15: Choroidal Neovascularization (CNV) Market Value Chain Analysis 2017-2018 (US$)
Table 16: Choroidal Neovascularization (CNV) Market Pricing Analysis 2018-2023 (US$)
Table 17: Choroidal Neovascularization (CNV) Market Opportunities Analysis 2018-2023 (US$)
Table 18: Choroidal Neovascularization (CNV) Market Product Life Cycle Analysis 2018-2023 (US$)
Table 19: Choroidal Neovascularization (CNV) Market Supplier Analysis 2017-2018 (US$)
Table 20: Choroidal Neovascularization (CNV) Market Distributor Analysis 2017-2018 (US$)
Table 21: Choroidal Neovascularization (CNV) Market Trend Analysis 2017-2018 (US$)
Table 22: Choroidal Neovascularization (CNV) Market Size 2017 (US$)
Table 23: Choroidal Neovascularization (CNV) Market Forecast Analysis 2018-2023 (US$)
Table 24: Choroidal Neovascularization (CNV) Market Sales Forecast Analysis 2018-2023 (Units)
Table 25: Choroidal Neovascularization (CNV) Market, Revenue & Volume,By Treatment Type, 2018-2023 ($)
Table 26: Choroidal Neovascularization (CNV) Market By Treatment Type, Revenue & Volume,By Angiogenesis Inhibitors Injection, 2018-2023 ($)
Table 27: Choroidal Neovascularization (CNV) Market By Treatment Type, Revenue & Volume,By Photodynamic Therapy, 2018-2023 ($)
Table 28: Choroidal Neovascularization (CNV) Market By Treatment Type, Revenue & Volume,By Laser photocoagulation, 2018-2023 ($)
Table 29: Choroidal Neovascularization (CNV) Market By Treatment Type, Revenue & Volume,By Low-dose Radiation Therapy, 2018-2023 ($)
Table 30: Choroidal Neovascularization (CNV) Market By Treatment Type, Revenue & Volume,By Surgery, 2018-2023 ($)
Table 31: Choroidal Neovascularization (CNV) Market, Revenue & Volume, By Type of Diagnosis, 2018-2023 ($)
Table 32: Choroidal Neovascularization (CNV) Market By Type of Diagnosis, Revenue & Volume,By Fluorescein angiography (FA), 2018-2023 ($)
Table 33: Choroidal Neovascularization (CNV) Market By Type of Diagnosis, Revenue & Volume,By Indocyanine green (ICG) angiography, 2018-2023 ($)
Table 34: Choroidal Neovascularization (CNV) Market By Type of Diagnosis, Revenue & Volume,By Spectral domain optical coherence tomography (OCT), 2018-2023 ($)
Table 35: North America Choroidal Neovascularization (CNV) Market, Revenue & Volume,By Treatment Type, 2018-2023 ($)
Table 36: North America Choroidal Neovascularization (CNV) Market, Revenue & Volume, By Type of Diagnosis, 2018-2023 ($)
Table 37: South america Choroidal Neovascularization (CNV) Market, Revenue & Volume,By Treatment Type, 2018-2023 ($)
Table 38: South america Choroidal Neovascularization (CNV) Market, Revenue & Volume, By Type of Diagnosis, 2018-2023 ($)
Table 39: Europe Choroidal Neovascularization (CNV) Market, Revenue & Volume,By Treatment Type, 2018-2023 ($)
Table 40: Europe Choroidal Neovascularization (CNV) Market, Revenue & Volume, By Type of Diagnosis, 2018-2023 ($)
Table 41: APAC Choroidal Neovascularization (CNV) Market, Revenue & Volume,By Treatment Type, 2018-2023 ($)
Table 42: APAC Choroidal Neovascularization (CNV) Market, Revenue & Volume, By Type of Diagnosis, 2018-2023 ($)
Table 43: Middle East & Africa Choroidal Neovascularization (CNV) Market, Revenue & Volume,By Treatment Type, 2018-2023 ($)
Table 44: Middle East & Africa Choroidal Neovascularization (CNV) Market, Revenue & Volume, By Type of Diagnosis, 2018-2023 ($)
Table 45: Russia Choroidal Neovascularization (CNV) Market, Revenue & Volume,By Treatment Type, 2018-2023 ($)
Table 46: Russia Choroidal Neovascularization (CNV) Market, Revenue & Volume, By Type of Diagnosis, 2018-2023 ($)
Table 47: Israel Choroidal Neovascularization (CNV) Market, Revenue & Volume,By Treatment Type, 2018-2023 ($)
Table 48: Israel Choroidal Neovascularization (CNV) Market, Revenue & Volume, By Type of Diagnosis, 2018-2023 ($)
Table 49: Top Companies 2017 (US$)Choroidal Neovascularization (CNV) Market, Revenue & Volume
Table 50: Product Launch 2017-2018Choroidal Neovascularization (CNV) Market, Revenue & Volume
Table 51: Mergers & Acquistions 2017-2018Choroidal Neovascularization (CNV) Market, Revenue & Volume


List of Figures
Figure 1: Overview of Choroidal Neovascularization (CNV) Market 2017-2023
Figure 2: Market Share Analysis for Choroidal Neovascularization (CNV) Market 2017 (US$)
Figure 3: Product Comparison in Choroidal Neovascularization (CNV) Market 2017-2018 (US$)
Figure 4: End User Profile for Choroidal Neovascularization (CNV) Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in Choroidal Neovascularization (CNV) Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Choroidal Neovascularization (CNV) Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in Choroidal Neovascularization (CNV) Market 2017-2018
Figure 8: Ecosystem Analysis in Choroidal Neovascularization (CNV) Market 2017
Figure 9: Average Selling Price in Choroidal Neovascularization (CNV) Market 2017-2023
Figure 10: Top Opportunites in Choroidal Neovascularization (CNV) Market 2017-2018
Figure 11: Market Life Cycle Analysis in Choroidal Neovascularization (CNV) Market Market Life Cycle Analysis in 3D Printing
Figure 12: GlobalBy Treatment Type Choroidal Neovascularization (CNV) Market Revenue, 2018-2023 ($)
Figure 13: Global By Type of Diagnosis Choroidal Neovascularization (CNV) Market Revenue, 2018-2023 ($)
Figure 14: Global Choroidal Neovascularization (CNV) Market - By Geography
Figure 15: Global Choroidal Neovascularization (CNV) Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 16: Global Choroidal Neovascularization (CNV) Market CAGR, By Geography, 2018-2023 (%)
Figure 17: North America Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 18: US Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 19: US GDP and Population, 2017-2018 ($)
Figure 20: US GDP – Composition of 2017, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2017-2018 ($)
Figure 22: Canada Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 23: Canada GDP and Population, 2017-2018 ($)
Figure 24: Canada GDP – Composition of 2017, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 26: Mexico Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 27: Mexico GDP and Population, 2017-2018 ($)
Figure 28: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 30: South America Choroidal Neovascularization (CNV) Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 31: Brazil Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 32: Brazil GDP and Population, 2017-2018 ($)
Figure 33: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 35: Venezuela Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 36: Venezuela GDP and Population, 2017-2018 ($)
Figure 37: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 39: Argentina Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 40: Argentina GDP and Population, 2017-2018 ($)
Figure 41: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 43: Ecuador Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 44: Ecuador GDP and Population, 2017-2018 ($)
Figure 45: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 47: Peru Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 48: Peru GDP and Population, 2017-2018 ($)
Figure 49: Peru GDP – Composition of 2017, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 51: Colombia Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 52: Colombia GDP and Population, 2017-2018 ($)
Figure 53: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 55: Costa Rica Choroidal Neovascularization (CNV) Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 56: Costa Rica GDP and Population, 2017-2018 ($)
Figure 57: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 59: Europe Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 60: U.K Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 61: U.K GDP and Population, 2017-2018 ($)
Figure 62: U.K GDP – Composition of 2017, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 64: Germany Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 65: Germany GDP and Population, 2017-2018 ($)
Figure 66: Germany GDP – Composition of 2017, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 68: Italy Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 69: Italy GDP and Population, 2017-2018 ($)
Figure 70: Italy GDP – Composition of 2017, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 72: France Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 73: France GDP and Population, 2017-2018 ($)
Figure 74: France GDP – Composition of 2017, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2017-2018 ($)
Figure 76: Netherlands Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 77: Netherlands GDP and Population, 2017-2018 ($)
Figure 78: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 80: Belgium Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 81: Belgium GDP and Population, 2017-2018 ($)
Figure 82: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 84: Spain Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 85: Spain GDP and Population, 2017-2018 ($)
Figure 86: Spain GDP – Composition of 2017, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 88: Denmark Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 89: Denmark GDP and Population, 2017-2018 ($)
Figure 90: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 92: APAC Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 93: China Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023
Figure 94: China GDP and Population, 2017-2018 ($)
Figure 95: China GDP – Composition of 2017, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2017-2018 ($)Choroidal Neovascularization (CNV) Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 97: Australia Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 98: Australia GDP and Population, 2017-2018 ($)
Figure 99: Australia GDP – Composition of 2017, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 101: South Korea Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 102: South Korea GDP and Population, 2017-2018 ($)
Figure 103: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 105: India Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 106: India GDP and Population, 2017-2018 ($)
Figure 107: India GDP – Composition of 2017, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2017-2018 ($)
Figure 109: Taiwan Choroidal Neovascularization (CNV) Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 110: Taiwan GDP and Population, 2017-2018 ($)
Figure 111: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 113: Malaysia Choroidal Neovascularization (CNV) Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 114: Malaysia GDP and Population, 2017-2018 ($)
Figure 115: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 117: Hong Kong Choroidal Neovascularization (CNV) Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 118: Hong Kong GDP and Population, 2017-2018 ($)
Figure 119: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 121: Middle East & Africa Choroidal Neovascularization (CNV) Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 122: Russia Choroidal Neovascularization (CNV) Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 123: Russia GDP and Population, 2017-2018 ($)
Figure 124: Russia GDP – Composition of 2017, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 126: Israel Choroidal Neovascularization (CNV) Market Value & Volume, 2018-2023 ($)
Figure 127: Israel GDP and Population, 2017-2018 ($)
Figure 128: Israel GDP – Composition of 2017, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 130: Entropy Share, By Strategies, 2017-2018* (%)Choroidal Neovascularization (CNV) Market 
Figure 131: Developments, 2017-2018*Choroidal Neovascularization (CNV) Market 
Figure 132: Company 1 Choroidal Neovascularization (CNV) Market Net Revenue, By Years, 2017-2018* ($)
Figure 133: Company 1 Choroidal Neovascularization (CNV) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 134: Company 1 Choroidal Neovascularization (CNV) Market Net Sales Share, By Geography, 2017 (%)
Figure 135: Company 2 Choroidal Neovascularization (CNV) Market Net Revenue, By Years, 2017-2018* ($)
Figure 136: Company 2 Choroidal Neovascularization (CNV) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 137: Company 2 Choroidal Neovascularization (CNV) Market Net Sales Share, By Geography, 2017 (%)
Figure 138: Company 3Choroidal Neovascularization (CNV) Market Net Revenue, By Years, 2017-2018* ($)
Figure 139: Company 3Choroidal Neovascularization (CNV) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 140: Company 3Choroidal Neovascularization (CNV) Market Net Sales Share, By Geography, 2017 (%)
Figure 141: Company 4 Choroidal Neovascularization (CNV) Market Net Revenue, By Years, 2017-2018* ($)
Figure 142: Company 4 Choroidal Neovascularization (CNV) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 143: Company 4 Choroidal Neovascularization (CNV) Market Net Sales Share, By Geography, 2017 (%)
Figure 144: Company 5 Choroidal Neovascularization (CNV) Market Net Revenue, By Years, 2017-2018* ($)
Figure 145: Company 5 Choroidal Neovascularization (CNV) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 146: Company 5 Choroidal Neovascularization (CNV) Market Net Sales Share, By Geography, 2017 (%)
Figure 147: Company 6 Choroidal Neovascularization (CNV) Market Net Revenue, By Years, 2017-2018* ($)
Figure 148: Company 6 Choroidal Neovascularization (CNV) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 149: Company 6 Choroidal Neovascularization (CNV) Market Net Sales Share, By Geography, 2017 (%)
Figure 150: Company 7 Choroidal Neovascularization (CNV) Market Net Revenue, By Years, 2017-2018* ($)
Figure 151: Company 7 Choroidal Neovascularization (CNV) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 152: Company 7 Choroidal Neovascularization (CNV) Market Net Sales Share, By Geography, 2017 (%)
Figure 153: Company 8 Choroidal Neovascularization (CNV) Market Net Revenue, By Years, 2017-2018* ($)
Figure 154: Company 8 Choroidal Neovascularization (CNV) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 155: Company 8 Choroidal Neovascularization (CNV) Market Net Sales Share, By Geography, 2017 (%)
Figure 156: Company 9 Choroidal Neovascularization (CNV) Market Net Revenue, By Years, 2017-2018* ($)
Figure 157: Company 9 Choroidal Neovascularization (CNV) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 158: Company 9 Choroidal Neovascularization (CNV) Market Net Sales Share, By Geography, 2017 (%)
Figure 159: Company 10 Choroidal Neovascularization (CNV) Market Net Revenue, By Years, 2017-2018* ($)
Figure 160: Company 10 Choroidal Neovascularization (CNV) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 161: Company 10 Choroidal Neovascularization (CNV) Market Net Sales Share, By Geography, 2017 (%)
Figure 162: Company 11 Choroidal Neovascularization (CNV) Market Net Revenue, By Years, 2017-2018* ($)
Figure 163: Company 11 Choroidal Neovascularization (CNV) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 164: Company 11 Choroidal Neovascularization (CNV) Market Net Sales Share, By Geography, 2017 (%)
Figure 165: Company 12 Choroidal Neovascularization (CNV) Market Net Revenue, By Years, 2017-2018* ($)
Figure 166: Company 12 Choroidal Neovascularization (CNV) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 167: Company 12 Choroidal Neovascularization (CNV) Market Net Sales Share, By Geography, 2017 (%)
Figure 168: Company 13Choroidal Neovascularization (CNV) Market Net Revenue, By Years, 2017-2018* ($)
Figure 169: Company 13Choroidal Neovascularization (CNV) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 170: Company 13Choroidal Neovascularization (CNV) Market Net Sales Share, By Geography, 2017 (%)
Figure 171: Company 14 Choroidal Neovascularization (CNV) Market Net Revenue, By Years, 2017-2018* ($)
Figure 172: Company 14 Choroidal Neovascularization (CNV) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 173: Company 14 Choroidal Neovascularization (CNV) Market Net Sales Share, By Geography, 2017 (%)
Figure 174: Company 15 Choroidal Neovascularization (CNV) Market Net Revenue, By Years, 2017-2018* ($)
Figure 175: Company 15 Choroidal Neovascularization (CNV) Market Net Revenue Share, By Business segments, 2017 (%)
Figure 176: Company 15 Choroidal Neovascularization (CNV) Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll